METTL3 is overexpressed in GC tissues, enhancing FNTA translation through YTHDF1-dependent m6A modifications, maintaining KRAS membrane localization and continuously activating the MEK/ERK pathway, driving tumor progression and metastasis. The gene discussed is METTL3; the disease is neoplasm.